| Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | New England Journal of Medicine | 2012 | 8.7K |
| The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews Cancer | 2012 | 8.1K |
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Nature | 2008 | 5.7K |
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | New England Journal of Medicine | 2015 | 5.6K |
| Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer | New England Journal of Medicine | 2015 | 5.5K |
| Safety and activity of anti-PD-L1 antibody in patients with advanced cancer | New England Journal of Medicine | 2012 | 5.5K |
| Integrated genomic analyses of ovarian carcinoma | Nature | 2011 | 5.2K |
| The fundamental role of epigenetic events in cancer | Nature Reviews Genetics | 2002 | 4.3K |
| Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Nature | 2010 | 4K |
| Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma | New England Journal of Medicine | 2015 | 3.7K |
| The epigenomics of cancer | Cell | 2007 | 3.5K |
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade | Science | 2017 | 3.3K |
| Cancer genes and the pathways they control | Nature Medicine | 2004 | 3.2K |
| Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 | Cell | 2004 | 3.1K |
| STATs in cancer inflammation and immunity: a leading role for STAT3 | Nature Reviews Cancer | 2009 | 2.9K |
| The consensus coding sequences of human breast and colorectal cancers | Science | 2006 | 2.8K |
| Integrated genomic characterization of endometrial carcinoma | Nature | 2013 | 2.8K |
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Science Translational Medicine | 2014 | 2.7K |
| The genomic landscapes of human breast and colorectal cancers | Science | 2007 | 2.7K |
| Gene silencing in cancer in association with promoter hypermethylation | New England Journal of Medicine | 2003 | 2.7K |
| High frequency of mutations of the PIK3CA gene in human cancers | Science | 2004 | 2.7K |
| PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma | New England Journal of Medicine | 2015 | 2.5K |
| c-Myc-regulated microRNAs modulate E2F1 expression | Nature | 2005 | 2.4K |
| Immune checkpoint blockade: a common denominator approach to cancer therapy | Cancer Cell | 2015 | 2.4K |
| Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer | New England Journal of Medicine | 2003 | 2.3K |
